Small Activating Rna
Small Activating Rna - Related Videos
04:10
Helicase Activity Measurement of a Target Protein Using Biotin-Labeled RNA Duplexes
0 Views •
2025
In this video, we demonstrate the procedure to determine the helicase activity of a target protein to unwind the biotin-labeled dsRNA substrate. The activity of the enzyme was identified by analyzing the electrophoretic mobility shift, followed by a chemiluminescence assay using chemiluminescent enzyme-conjugated streptavidin.
08:31
Antibody-Free Assay for RNA Methyltransferase Activity Analysis
0 Views •
2019
Here, an antibody-free in vitro assay for direct analysis of methyltransferase activity on synthetic or in vitro transcribed RNA is described.
10:05
Studying RNA Interactors of Protein Kinase RNA-Activated during the Mammalian Cell Cycle
0 Views •
Cited by 1 •
2019
We present experimental approaches for studying RNA-interactors of double-stranded RNA binding protein kinase RNA-activated (PKR) during the mammalian cell cycle using HeLa cells. This method utilizes formaldehyde to crosslink RNA-PKR complexes and immunoprecipitation to enrich PKR-bound RNAs. These RNAs can be further analyzed through high-throughput sequencing or qRT-PCR.
01:53
RNA Stability
0 Views •
2019
Intact DNA strands can be found in fossils, while scientists sometimes struggle to keep RNA intact under laboratory conditions. The structural variations between RNA and DNA underlie the differences in their stability and longevity. Because DNA is double-stranded, it is inherently more stable. The single-stranded structure of RNA is less stable but also more flexible and can form weak internal bonds. Additionally, most RNAs in the cell are relatively short, while DNA can be up to 250 million...
09:19
RNA Catalyst as a Reporter for Screening Drugs against RNA Editing in Trypanosomes
0 Views •
Cited by 1 •
2014
A highly sensitive ribozyme-based assay, applicable to high-throughput screening of chemicals targeting the unique process of RNA editing in trypanosomatid pathogens, is described in this paper. Inhibitors can be used as tools for hypothesis-driven analysis of the RNA editing process and ultimately as therapeutics.
FAQs
The relevant sequence relationship is complementarity between the saRNA and a promoter or enhancer associated with the selected gene. That pairing gives the molecule a basis for directing regulatory activity to a particular genomic control region rather than producing a generalized change in expression. In medicine, this specificity supports investigation of defined gene targets whose increased expression could alter cellular function.
Argonaute proteins can associate with Small Activating Rna after the molecule enters a cell. This association helps connect the RNA guide with regulatory complexes that recognize a complementary promoter or enhancer region. The resulting interaction provides a molecular route for directing gene-regulatory activity to a selected genomic site, where transcriptional effects may follow.
Targeting a promoter or enhancer may influence the local regulatory environment surrounding a gene. According to the proposed mechanism, saRNA-guided complexes can alter chromatin structure and recruit transcriptional machinery at these control regions. These changes may make increased transcription possible, linking recognition of a complementary sequence with expression of the selected gene.
Several linked events shape the potential outcome: the saRNA must enter cells, associate with Argonaute proteins, and guide regulatory complexes toward a complementary promoter or enhancer. The response may then depend on how those complexes affect chromatin structure and transcriptional machinery. Together, these steps determine whether activation of the selected gene can influence cellular function.
A typical conceptual workflow follows the molecule from cellular entry to gene regulation. Researchers examine whether saRNA associates with Argonaute proteins, guides regulatory complexes to the intended promoter or enhancer, and produces changes linked to chromatin or transcriptional machinery. The final focus is whether expression of the selected gene increases in a way relevant to the research question.
The approach is being investigated when increasing expression of an existing gene could restore a protective protein or compensate for deficient protein production. Rather than focusing only on supplying a protein, researchers examine whether sequence-specific activation of the corresponding endogenous gene can improve cellular function. This rationale connects saRNA research with therapeutic investigation in medicine.
Small Activating Rna research extends across several medical areas, including cancer, cardiovascular disease, and tissue repair. In these settings, investigators may select genes whose increased expression could support protective functions or regeneration. The same gene-activation concept is therefore relevant both to therapeutic research and to regenerative medicine, where restoring cellular activity may be an important objective.